The Food and Drug Administration approved Zepbound ... to treat sleepapnea on Friday—marking a significant win for the drug company Eli Lilly, which had Zepbound approved as a weight-loss ...
Dec. 21 (UPI) --Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has been approved by the Food and Drug Administration for treating moderate to severe obstructive sleepapnea.
Results that may be inaccessible to you are currently showing.